USFDA issues warning letter to Cipla for Goa manufacturing facility
The company said that it remains committed to maintain highest standards of compliance and will work closely with the agency to…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Cipla
Eminence Business Media concludes 3rd Annual Pharma Project and Portfolio Management Summit 2020
The theme of the summit was 'Grooming Project and Portfolio Management teams for opportunities and uncertainties'
Eminence…
Cipla SA signs agreement for anti-psychotic drug
The agreement involves AstraZeneca Pharmaceuticals, the originator of the Medicine, and Luye Pharma Hong Kong, which acquired the…
Cipla acquires four nutraceutical brands of Wanbury
The nutraceutical products will address various health needs for conditions arising due to nutritional deficiencies or…
Cipla announces unaudited consolidated financial results for Q3 FY20
Growth across key business drove overall revenue growth of 9 per cent on a year on year basis with adjusted EBITDA at 18.5 per…
Signs of progress against the superbugs, but not yet at the scale needed: Study
The 2020 Antimicrobial Resistance Benchmark evaluates how 30 pharmaceutical companies are limiting drug-resistance
Cipla announces closure of USFDA inspection at Patalganga facility
Following the inspection by USFDA in November last year, the company has received the Establishment Inspection Report (EIR),…
Cipla acquires brand, trademark rights for anti-diabetic drug Vysov in India
Cipla has been co-marketing Vildagliptin in agreement with Novartis under brand names Vysov and Vysov M (Vildagliptin plus…
Cipla shares rise marginally post agreement with CitiHealth Imports
On the BSE, the stock hit intra-day high of Rs 476.35, up 1.83 per cent. It settled 0.22 per cent up at Rs 468.80. On the BSE, the…
Cipla arm to acquire remaining stake in Cipla Pharma Lanka
Cipla (EU) already has a 60 per cent stake in Cipla Pharma Lanka Pvt Ltd. Post-acquisition, Cipla Pharma Lanka will become a…